Human Investing’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $1.54M | Buy |
3,657
+121
| +3% | +$48.2K | 0.2% | 34 |
|
|
2026
Q2 | $1.28M | Sell |
3,536
-46
| -1% | -$15.7K | 0.17% | 35 |
|
|
2026
Q1 | $1.26M | Sell |
3,582
-15
| -0.4% | -$5.35K | 0.18% | 32 |
|
|
2025
Q4 | $1.18M | Buy |
3,597
+281
| +8% | +$89.1K | 0.17% | 37 |
|
|
2025
Q3 | $936K | Sell |
3,316
-1,131
| -25% | -$328K | 0.14% | 43 |
|
|
2025
Q2 | $1.24M | Buy |
4,447
+103
| +2% | +$29.2K | 0.2% | 35 |
|
|
2025
Q1 | $1.35M | Sell |
4,344
-363
| -8% | -$107K | 0.24% | 34 |
|
|
2024
Q4 | $1.23M | Buy |
4,707
+5
| +0.1% | +$1.48K | 0.22% | 36 |
|
|
2024
Q3 | $1.52M | Sell |
4,702
-46
| -1% | -$15K | 0.27% | 32 |
|
|
2024
Q2 | $1.48M | Sell |
4,748
-370
| -7% | -$109K | 0.29% | 33 |
|
|
2024
Q1 | $1.46M | Sell |
5,118
-147
| -3% | -$43K | 0.29% | 33 |
|
|
2023
Q4 | $1.52M | Sell |
5,265
-1,593
| -23% | -$434K | 0.33% | 32 |
|
|
2023
Q3 | $1.84M | Buy |
6,858
+2,049
| +43% | +$511K | 0.43% | 30 |
|
|
2023
Q2 | $1.07M | Sell |
4,809
-332
| -6% | -$77K | 0.24% | 38 |
|
|
2023
Q1 | $1.24M | Sell |
5,141
-881
| -15% | -$216K | 0.3% | 34 |
|
|
2022
Q4 | $1.58M | Sell |
6,022
-1,466
| -20% | -$393K | 0.4% | 32 |
|
|
2022
Q3 | $1.69M | Sell |
7,488
-177
| -2% | -$42.9K | 0.43% | 33 |
|
|
2022
Q2 | $1.86M | Sell |
7,665
-150
| -2% | -$36.8K | 0.45% | 30 |
|
|
2022
Q1 | $1.89M | Buy |
+7,815
| New | +$1.8M | 0.42% | 34 |
|
|
2021
Q4 | – | Sell |
-8,366
| Closed | -$1.78M | – | 74 |
|
|
2021
Q3 | $1.78M | Buy |
8,366
+16
| +0.2% | +$3.68K | 0.42% | 35 |
|
|
2021
Q2 | $2.04M | Buy |
8,350
+148
| +2% | +$36.4K | 0.5% | 33 |
|
|
2021
Q1 | $2.04M | Sell |
8,202
-660
| -7% | -$157K | 0.52% | 30 |
|
|
2020
Q4 | $2.04M | Sell |
8,862
-447
| -5% | -$103K | 0.58% | 30 |
|
|
2020
Q3 | $2.37M | Sell |
9,309
-377
| -4% | -$93.4K | 0.78% | 27 |
|
|
2020
Q2 | $2.28M | Sell |
9,686
-1,042
| -10% | -$238K | 0.81% | 24 |
|
|
2020
Q1 | $2.18M | Sell |
10,728
-1,398
| -12% | -$305K | 0.94% | 17 |
|
|
2019
Q4 | $2.92M | Sell |
12,126
-410
| -3% | -$90.4K | 0.95% | 20 |
|
|
2019
Q3 | $2.43M | Buy |
12,536
+4,657
| +59% | +$894K | 0.86% | 24 |
|
|
2019
Q2 | $1.45M | Buy |
7,879
+6,227
| +377% | +$1.11M | 0.53% | 56 |
|
|
2019
Q1 | $314K | Buy |
1,652
+34
| +2% | +$6.49K | 0.12% | 92 |
|
|
2018
Q4 | $315K | Buy |
+1,618
| New | +$316K | 0.13% | 99 |
|
Other funds holding AMGN
Human Investing's AMGN Position: Q3 2026 in Review
Human Investing increased its Amgen (AMGN) stake by 3.4% in Q3 2026, buying an estimated $48.2K and bringing the position to 3,657 shares worth $1.54M. The position accounts for 0.2% of the portfolio, ranked #34.
Human Investing first reported a position in AMGN in Q4 2018 and has held it in 31 quarters since. The position peaked at $2.92M in Q4 2019. 2,911 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.
- Human Investing held 3,657 shares of Amgen worth $1.54M as of Q3 2026.
- Human Investing bought 121 Amgen shares in Q3 2026, an estimated $48.2K.
- Amgen made up 0.2% of Human Investing's portfolio in Q3 2026, its #34 holding.
- Human Investing first reported a position in Amgen in Q4 2018 and has held it in 31 quarters since.
- Human Investing's Amgen position peaked at $2.92M in Q4 2019.
- 2,911 funds tracked by Wall St. Rank held Amgen as of Q3 2026.
Based on Human Investing's 13F filing for Q3 2026, filed 19 Oct 2026.